FDA drug candidacy acceptance criteria and steps: problems and way forward

dc.contributor.author	Ezzat, Shahira M
dc.contributor.author	Helmy, Mahitab
dc.contributor.author	Walag, Angelo Mark P
dc.contributor.author	Mtewa, Andrew
dc.date.accessioned	2020-01-23T15:13:27Z
dc.date.available	2020-01-23T15:13:27Z
dc.date.issued	2019-08
dc.identifier.other	https://doi.org/
dc.identifier.uri	https://t.ly/dgr3M
dc.language.iso	en_US	en_US
dc.publisher	Elsevier	en_US
dc.relation.ispartofseries	In book: Phytochemicals as Lead Compounds for New Drug Discovery, Publisher: Elsevier,;pp.39-63
dc.subject	university of	en_US
dc.title	FDA drug candidacy acceptance criteria and steps: problems and way forward	en_US
dc.type	Book chapter	en_US
dc.identifier.doi	https://doi.org/
dc.Affiliation	October University for modern sciences and Arts (MSA)